Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors
Drug Development Research · 2026
DOI: 10.1002/ddr.70206 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Drug Development Research, 2026. Verfasst von Jiayi Shen und 6 weiteren Autor:innen. Beteiligte Einrichtung: Jiangxi Province Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, Jiangxi, PR China. Hauptthemen laut MEDLINE: Syk Kinase, Protein Kinase Inhibitors, Drug Design. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 113 Literaturangaben.
Abstract (Originalsprache)
Spleen tyrosine kinase (SYK), a non‐receptor tyrosine kinase, serves as a pivotal regulator in multiple intracellular signaling pathways, particularly those involved in immune responses. Dysregulated SYK activation has been strongly implicated in the pathogenesis of various hematological malignancies and autoimmune disorders, making it an attractive therapeutic target. Consequently, significant progress has been made in developing SYK inhibitors as a targeted treatment strategy. This article comprehensively reviews recent advances in SYK inhibitor research, focusing on their therapeutic potential in autoimmune diseases and hematologic cancers. Furthermore, we highlight representative SYK inhibitors, discuss their clinical applications, outline current challenges, and future directions in this evolving field.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Jiangxi Province Key Laboratory of Synthetic Pharmaceutical Chemistry, Gannan Normal University, Ganzhou, Jiangxi, PR China.
- Jiangxi Chiralsyn Biological Medicine Co. LTD, Ganzhou, Jiangxi, China.
- Ganzhou General Inspection and Testing Institute, Ganzhou, Jiangxi, China.
ORCID-Profile: Jiayi Shen
Zitieren
APA
Shen, J., Lin, J., Li, A., Kong, Y., Chen, S., Li, G., & Li, Y. (2026). Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors. Drug Development Research. https://doi.org/10.1002/ddr.70206
Vancouver
Shen J, Lin J, Li A, Kong Y, Chen S, Li G, et al. Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors. Drug Development Research. 2026. doi:10.1002/ddr.70206
BibTeX
@article{Shen2026,
author = {Shen, Jiayi and Lin, Jieman and Li, Anzhi and Kong, Yunyi and Chen, Sheng and Li, Gonghui and Li, Yongdong},
title = {Recent Progress of Molecular Design and Activities of Spleen Tyrosine Kinase (SYK) Inhibitors},
journal = {Drug Development Research},
year = {2026},
doi = {10.1002/ddr.70206}
}
EUVIMED